期刊文献+

PCI术中血栓抽吸联合替罗非班对急性ST段抬高型心肌梗死的疗效观察 被引量:4

原文传递
导出
摘要 目的观察PCI术中血栓抽吸联合替罗非班在急性ST段抬高型心肌梗死(STEMI)患者中的疗效。方法 2010年8月至2012年8月住院治疗的急性STEMI患者118例,随机分为观察组(PCI+血栓抽吸联合替罗非班)62例和对照组(直接PCI)56例。观察PCI术后即刻TIMI血流分级、无复流发生率、球囊使用率、支架置入率、ST段回落率、肌钙蛋白T(TnT)峰值和肌酸激酶同工酶(CK-MB)峰值、左心室射血分数(LVEF)、6个月内主要心血管不良事件(MACE)的发生率。结果与对照组比较,观察组术后TIMI 3级血流发生率明显增高(P<0.01),无复流发生率明显减少(P<0.01),球囊使用率明显降低(P<0.01),两组支架植入率相当(P>0.05)。与对照组比较,观察组的TnT及CK-MB峰值显著降低(P均<0.01),心电图的ST段回落率、LVEF值明显增加(P<0.01,P<0.05),6个月内的心衰发生率、再次AMI发生率显著降低(P<0.01,P<0.05)。结论 PCI术中血栓抽吸联合替罗非班能明显降低急性STEMI患者冠脉内血栓负荷,改善冠脉血流,减小梗死面积,改善患者的预后。
作者 王大强
出处 《中国临床研究》 CAS 2014年第5期539-540,共2页 Chinese Journal of Clinical Research
  • 相关文献

参考文献10

二级参考文献47

  • 1YAN Hong-bing WANG Jian LI Nan ZHU Xiao-ling GAO Hai AI Hui LI Xiang YE Ming CHI Yun-peng ZHANG Hong.Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction:a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction[J].Chinese Medical Journal,2007(7):557-561. 被引量:29
  • 2Chan AW, Chen DP, Bhatt DL, et al. Long-term mortality benefit with the combination of stents and tirofiban for cardiogenic shockcomplicatiy complication after acute myocardial infarction. Am J Cardiology,2002,89:132-136.
  • 3Winter JP, Juergens CP. The role of tirofiban in the management of coronary artery disease. Cardiovasc Hematol Disord Drug Targets,2008,8: 138-146.
  • 4Petronioa AS, Rovai D, Musumeci G, et al. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute myocardial infarction treatd by primary coronary angioplasty. Eur Heart J,2003,24:67-76.
  • 5Brener SJ, Barr LA, Burchenal JE, et al. Randomized , placebo -controlled trial of platlet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocaydial infarction Reopro and Primary PTCA Organnization and Randomized Trial (RAPPORT) Investigators. Circulation, 1988,98:734-741.
  • 6Uyarel H, Uzunlar B, Unal DS, et al. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty. Cardiology,2006,105:168-175.
  • 7De Luca G, Smit JJ, Ernst N, et al. Impact of adjunctive tirofibanadminist ration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST segment elevation myocardial infarction. Thromb Haemost, 2005, 93: 820-823.
  • 8Wamho!.tz A, Osmd MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention induced endothelial dysfunction in patients with stable coronary artery disease. Am J Cardiol,2005,95:20-23.
  • 9Giuseppe DL, Eliano N, Paolo M. Risk profile and benefits from Gp IIb-Ilia inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J,2009, 30:2705-2713.
  • 10Valgimigli M, Campo G, Percoco G, et al. Comparison of angioplastywith infusion of tirofiban or abciximab and with implantation of sirolimus -eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA,2008,299:1788-1799.

共引文献33

同被引文献51

  • 1牛和平,张军,袁琛,付金国,费玲,万艳芳,王长厚.血栓抽吸在老年急性心肌梗死恢复期患者介入中的应用[J].中国老年学杂志,2014,34(12):3335-3337. 被引量:8
  • 2蔡舸,吕云,高彦.血栓抽吸联合替罗非班对老年急性心肌梗死择期经皮冠状动脉介入的运用价值[J].中国老年学杂志,2014,34(2):535-536. 被引量:6
  • 3Gennaro Sardella,Rocco Edoardo Stio.Thrombus aspiration in acute myocardial infarction:Rationale and indication[J].World Journal of Cardiology,2014,6(9):924-928. 被引量:15
  • 4Wang HL, Xing SY, Dong PS, et al. Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention[J]. European review for medical and pharmacological sci- ences, 2014, 18(23):3690-3695.
  • 5Wang K, Zuo G, Zheng L, et al. Effects of tirofiban on platelet activa- tion and endothelial function in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Cell biochemistry and biophysics,2015, 71( 1 ): 135-142.
  • 6Tanguay JF, Bell AD, Ackman ML, et al .Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy[J].The Canadian journal of cardiology,2013,29( 11 ): 1334-1345.
  • 7Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarc- tion after 1 year in the Thrombus Aspiration during Percutaneous coro- nary intervention in Acute myocardial infarction Study (TAPAS): a l- year follow-up study[J]. Lancet (London, England), 2008, 371(9628):1915-1920.
  • 8Gu YL, Kampinga MA, Wieringa WG, et al. Intracoronary versus intra- venous administration of abciximab in patients with ST-segment eleva- tion myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfu-sion of ST-segment elevation myocardial infarction (CICERO) trial[J]. Circulation, 2010, 122(25):2709-2717.
  • 9Akpek M, Sahin O, Sarli B, et al.Acute Effects of Intracoronary Tirofi- ban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary In- tervention[J]. Angiology, 2015,66(6):560-567.
  • 10薛鸿群,侯爱琴,李文国,孙萍.血栓抽吸导管联合替罗非班治疗急性心肌梗死临床观察[J].中国误诊学杂志,2011,11(9):2122-2123. 被引量:2

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部